SEC Form 4 · accession 0001209191-15-074366
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elaine Ullian
Director
Period of report
Oct 2, 2015
Accepted (ET)
Oct 6, 2015 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 2, 2015 | M | 20,000 | $34.24 | A | 25,265 | D | |
| Common StockF1 | Oct 2, 2015 | S | 20,000 | $110.00 | D | 5,265 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $34.24 | Oct 2, 2015 | M | 20,000 | D | — | May 31, 2020 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1Transaction made pursuant to M. Ullian's company approved trading plan under Rule 10b5-1.
- F2Fully vested.